ABBOTT DIAGNOSTICS SCARBOROUGH, INC. BINAXNOW COVID-19 AG CARD; LATERAL FLOW IMMUNOASSAY IVD OF COVID-19
|
Back to Search Results |
|
Catalog Number 195-000 |
Device Problem
False Negative Result (1225)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 11/25/2020 |
Event Type
malfunction
|
Manufacturer Narrative
|
The investigation is not yet complete.Upon completion, a supplemental report will be submitted to the fda.
|
|
Event Description
|
The customer reported a false negative on an immediately tested nasal kitted swab with binaxnow covid-19 ag card performed on (b)(6) 2020.The swab was used to collect samples from both nostrils, as indicated per product insert.6 drops of extraction reagent was added to the top hole of the test card.The customer thought (though he could not be sure) that the reagent was added before immediately inserting the swab.The swab was rotated 3 to 4 times clockwise.The test was read between 15 and twenty 20 minutes later.Confirmation testing by pcr performed on (b)(6) 2020 generated positive results (ct values not provided).The customer confirmed there was no death or serious injury based on binax now covid-19 ag result.The patient's treatment was not impacted or delayed based on the binax now covid-19 ag result.The patient was asymptomatic at the time of testing.The patient quarantined after receiving the positive covid-19 results.The customer stated it was the first time using the binaxnow covid-19 ag test.Negative results should be treated as presumptive and confirmation with a molecular assay, if necessary, for patient management, may be performed.Negative results do not rule out sars-cov-2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions.Negative results should be considered in the context of a patient's recent exposures, history and the presence of clinical signs and symptoms consistent with covid-19.Due to the risk of a potential false negative result leading to no or delayed treatment, this event shall be considered reportable.
|
|
Manufacturer Narrative
|
Testing was performed at abbott diagnostics (b)(4), inc.On retained kit lot 131710 with internal positive quality control samples and negative quality control swabs.All test results were valid and performed as expected.Additionally, the manufacturing batch records and quality control release testing for kit part number 195-000 / lot 131710 and device part number 195-430h / lot 129640a were reviewed.This lot met the required release specifications.A review of the complaints reported as false negative patient results (confirmed and unconfirmed, conflicting results) related to kit lot 131710 showed that the complaint rate is (b)(4).Abbott diagnostics (b)(4), inc.Was unable to determine the exact root cause of the reported issue.The available evidence suggests that this device lot is performing within the statements made within package insert related to % test agreement with the expected results by sample concentration.
|
|
Manufacturer Narrative
|
Correction to root cause: abbott diagnostics (b)(4) was unable to determine the exact root cause of the reported issue; however, it could possibly be related to the specific patient sample.
|
|
Search Alerts/Recalls
|
|
|